Despite a weaker production result in its third quarter, Coronado Resources has benefitted from strong price realisation
Tim Boreham notes small caps with cash on the balance sheet are the safer bet compared to ‘pre-revenue’ companies, and highlights several examples
A solid first quarter has not been enough for analysts to find upside value in Pilbara Minerals
Imricor is a player in a global catheter ablation market worth $US5.5 billion and growing at a compound rate of just over 8% a year
Baby Bunting has implemented plans to address a -230 basis point gross profit decline year-to-date and analysts expect some recovery can be made
Tyro Payment targets cost savings in a renewed focus on earnings under new management
The acquisition of Smart and Biggar opens up a pathway to replicating the consolidation success IPL Ltd has experienced in Australia in the Canadian market
Brokers ratchet target prices higher on a positive outlook for Karoon Energy
New broker research reinforces the global opportunity for Life360 to become a dominant brand
Pharmaxis might be two clinical studies away from rehabilitation, reports Tim Boreham